Mannkind Corp balance sheet
At the end of fiscal 2025, Mannkind Corp had total assets of $792m, total liabilities of $843m and shareholders' equity of −$51.0m. It held $74.9m in cash against $361m of debt: net debt of $286m.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 66 | 3 | 62 | 71 | 121 | 59 | 23 | 44 | 71 | 30 | 67 | 124 | 70 | 238 | 46 | 75 | 53 |
| Receivables | — | — | — | — | 50 | 0 | 0 | 3 | 4 | 4 | 4 | 5 | 17 | 15 | 12 | 38 | 43 |
| Inventory | — | — | — | — | 10 | — | 2 | 3 | 4 | 4 | 5 | 7 | 22 | 29 | 28 | 35 | 44 |
| Total current assets | 74 | 6 | 67 | 76 | 201 | 77 | 77 | 57 | 82 | 61 | 79 | 219 | 235 | 373 | 268 | 292 | 246 |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | 2 | 2 | 2 | 68 | 68 |
| Total assets | 277 | 200 | 251 | 259 | 394 | 126 | 107 | 85 | 108 | 94 | 109 | 321 | 295 | 475 | 394 | 792 | 732 |
| Accounts payable | 3 | 5 | 5 | 4 | 7 | 16 | 3 | 7 | 5 | 5 | 6 | 7 | 11 | 10 | 7 | 9 | 11 |
| Deferred revenue (current) | — | — | — | — | 197 | 140 | 3 | 0 | 37 | 33 | 33 | 1 | 2 | 9 | 12 | 15 | 11 |
| Total current liabilities | 18 | 25 | 145 | 128 | 403 | 268 | 92 | 88 | 75 | 66 | 74 | 48 | 67 | 104 | 82 | 171 | 143 |
| Short-term debt | — | — | — | — | — | — | — | — | — | 5 | — | — | — | — | — | — | — |
| Long-term debt | 209 | 211 | 98 | 98 | — | 28 | 28 | 157 | 102 | 114 | 122 | 281 | 273 | 269 | 36 | 355 | 319 |
| Total debt | 209 | 211 | 212 | 102 | 172 | 28 | 28 | 157 | 102 | 124 | 123 | 288 | 279 | 272 | 36 | 361 | 325 |
| Total liabilities | 463 | 513 | 362 | 289 | 468 | 477 | 291 | 299 | 283 | 284 | 289 | 531 | 546 | 721 | 473 | 843 | 800 |
| Shareholders' equity | −186 | −314 | −111 | −31 | −74 | −350 | −184 | −215 | −175 | −191 | −180 | −209 | −251 | −246 | −79 | −51 | −67 |
| Net debt (negative = net cash) | 143 | 208 | 150 | 32 | 51 | −31 | 5 | 113 | 31 | 94 | 56 | 164 | 209 | 34 | −10 | 286 | 272 |
| Shares outstanding | 128m | 132m | — | — | — | 86m | 96m | 119m | — | 212m | 242m | 251m | 264m | 270m | 303m | 308m | 310m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 18 | 12 | 29 | 27 | 17 | 38 | 28 | 43 |
| Inventory | 27 | 28 | 29 | 28 | 27 | 35 | 49 | 44 |
| Total current assets | 328 | 268 | 274 | 279 | 359 | 292 | 251 | 246 |
| Goodwill | 2 | 2 | 2 | 2 | 2 | 68 | 68 | 68 |
| Total assets | 464 | 394 | 410 | 412 | 495 | 792 | 744 | 732 |
| Accounts payable | 6 | 7 | 5 | 10 | 7 | 9 | 16 | 11 |
| Deferred revenue (current) | 7 | 12 | 12 | 11 | 10 | 15 | 12 | 11 |
| Total current liabilities | 72 | 82 | 116 | 112 | 109 | 171 | 135 | 143 |
| Long-term debt | 228 | 36 | 36 | 36 | 110 | 355 | 319 | 319 |
| Total debt | 228 | 36 | 36 | 36 | 110 | 355 | 319 | 319 |
| Total liabilities | 674 | 473 | 469 | 467 | 539 | 843 | 804 | 800 |
| Shareholders' equity | −210 | −79 | −59 | −55 | −45 | −51 | −59 | −67 |
| Shares outstanding | 276m | 303m | 304m | 306m | 307m | 308m | 309m | 310m |
Compare with peers
- Meiragtx Holdings plc balance sheet
- Sinovac Biotech LTD balance sheet
- Pharming Group N.V. balance sheet
- Novavax Inc balance sheet
- Ardelyx, Inc. balance sheet
Head to head: MGTX vs MNKDMNKD vs SVAMNKD vs PHARMNKD vs NVAX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies